Search PDMR transactions

Notifier
Name
Klaus Lykke Sindahl
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Klaus Lykke Sindahl
Position
VP, Head of Investor Relations
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name
Klaus Sindahl
LEI
549300LLEO25ZJJ3NT91
Details of transaction
Type of financial instrument Name ISIN code Nature of transaction Linked to a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Hansa Biopharma AB SE0002148817 Acquisition 300 Quantity 256.00 SEK 11/08/2020 NASDAQ STOCKHOLM AB
Aggregation
Name ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Hansa Biopharma AB SE0002148817 Acquisition 11/08/2020 NASDAQ STOCKHOLM AB 300 (Quantity) 256.00 SEK
Total: 300
<< Back